Colchicine 1 MG Oral Tablet

DRUG3 trials

Sponsors

Azienda Ospedaliero-Universitaria di Modena, University Of Perugia, I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Conditions

Amyotrophic Lateral SclerosisCOVID-19Calcium Pyrophosphate Deposition DiseaseChondrocalcinosis

Phase 2

Colchicine for Amyotrophic Lateral Sclerosis

CompletedNCT03693781

Azienda Ospedaliero-Universitaria di ModenaAmyotrophic Lateral Sclerosis

Start: 2019-04-10End: 2023-01-03Updated: 2023-03-01

Colchicine in COVID-19: a Pilot Study

TerminatedNCT04375202

University Of PerugiaCOVID-19

Start: 2020-04-18End: 2021-10-31Updated: 2022-11-07

Baricitinib in CPPD - the BAPTIST Study

Not yet recruitingNCT06768294

I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCalcium Pyrophosphate Deposition Disease, Chondrocalcinosis

Start: 2025-01-31End: 2027-01-31Target: 32Updated: 2025-01-10

Related Papers

Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)

BMJ Open2019-05-0163 citations